Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer

✍ Scribed by Ko, A H; Hwang, J; Venook, A P; Abbruzzese, J L; Bergsland, E K; Tempero, M A

• Book ID: 109998572
• Publisher: Nature Publishing Group
• Year: 2005
• Tongue: English
• Weight: 90 KB
• Volume: 93
• Category: Article
• ISSN: 0007-0920
• DOI: 10.1038/sj.bjc.6602687